# Ganirelix Acetate

NDC: 65219-028
Generic name: Ganirelix Acetate
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20230324

FDA application: ANDA215658

## Active ingredients

- GANIRELIX ACETATE: 250 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-028"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-028
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c23ca7b2-7350-4f07-8adf-046bffb47842